What is Rolling Review?
Rolling review is an
innovative regulatory approach primarily used to expedite the evaluation of new medical products, including vaccines and treatments, during public health emergencies. Unlike the traditional process where all data is submitted at once, rolling review allows regulatory bodies to assess data as it becomes available.
Speed: It accelerates the availability of potentially life-saving interventions.
Flexibility: Continuous feedback allows for modifications based on real-time data.
Transparency: Ongoing communication between developers and regulatory bodies can enhance public trust.
Applications in Public Health Emergencies
Rolling review has been prominently used during the
COVID-19 pandemic to facilitate the rapid development and approval of vaccines and treatments. The approach has shown that it can significantly reduce the time needed to bring effective medical interventions to the market without compromising on
safety and efficacy.
Challenges and Limitations
Despite its advantages, rolling review is not without challenges: Resource Intensive: Continuous review requires significant resources and manpower.
Data Quality: Incomplete data sets may lead to uncertainties in the assessment.
Regulatory Variability: Different countries may have varying guidelines, complicating global coordination.
Future of Rolling Review
As the field of epidemiology continues to evolve, rolling review is likely to become a standard part of the regulatory toolkit, especially in times of crisis. The lessons learned from its application during the COVID-19 pandemic could inform its use in future
public health emergencies, potentially making it a cornerstone of rapid response strategies.